Morgan Stanley Institutional Vitality Portfolio (MSVOX)
| Fund Assets | 1.89M |
| Expense Ratio | 0.90% |
| Min. Investment | $10,000,000 |
| Turnover | 19.00% |
| Dividend (ttm) | 0.01 |
| Dividend Yield | 0.14% |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 11, 2024 |
| Previous Close | 5.45 |
| YTD Return | -6.01% |
| 1-Year Return | -13.06% |
| 5-Year Return | n/a |
| 52-Week Low | 4.85 |
| 52-Week High | 6.59 |
| Beta (5Y) | 0.99 |
| Holdings | 37 |
| Inception Date | Dec 31, 2021 |
About MSVOX
Morgan Stanley Vitality Portfolio is a U.S.-focused mutual fund that seeks long-term capital appreciation by investing primarily in healthcare companies. The fund targets firms that are engaged in the discovery, development, production, or distribution of healthcare-related products and services, emphasizing those with strong research and development pipelines, sustainable competitive advantages, and robust financial profiles. Its portfolio is conviction-weighted and highly active, often differing significantly from standard healthcare benchmarks, with a concentrated set of holdings dominated by leading biotech, pharmaceutical, and healthcare technology firms. The portfolio’s investment team applies rigorous research to identify innovative companies poised to benefit from advances in healthcare, resulting in notable exposure to biotechnology, pharmaceuticals, and health care technology sectors. The fund’s role in the market is to offer investors access to high-growth potential in the dynamic healthcare industry, endeavoring to outperform broader equity indices through focused stock selection and active management within a vital sector of the economy.
Performance
MSVOX had a total return of -13.06% in the past year, including dividends. Since the fund's inception, the average annual return has been -4.14%.
Top 10 Holdings
55.32% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.02% |
| Argenx SE | n/a | 7.67% |
| UnitedHealth Group Incorporated | UNH | 6.11% |
| Vertex Pharmaceuticals Incorporated | VRTX | 5.27% |
| Exact Sciences Corporation | EXAS | 5.12% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 4.86% |
| Thermo Fisher Scientific Inc. | TMO | 4.84% |
| Intuitive Surgical, Inc. | ISRG | 4.69% |
| Ascendis Pharma A/S | ASND | 4.19% |
| Zoetis Inc. | ZTS | 3.55% |